126 related articles for article (PubMed ID: 2981381)
21. Stereoselectivity of kappa-opiate receptor ligands in inhibiting the binding of [3H][3-MeHis2]thyrotrophin releasing hormone to brain membranes.
Bhargava HN; Das S; Gulati A
J Pharm Pharmacol; 1988 Jan; 40(1):70-2. PubMed ID: 2896784
[TBL] [Abstract][Full Text] [Related]
22. Morphine antagonizes TRH induced intestinal transit and hyperserotonemia in rabbits.
Mori T; Carino MA; Horita A
Proc West Pharmacol Soc; 1987; 30():409-10. PubMed ID: 3114753
[No Abstract] [Full Text] [Related]
23. Agonist and antagonist properties of some benzomorphans on nociceptive reaction and intestinal transit in rats.
Gambino MC; Petrillo P; Tavani A
Life Sci; 1983; 33 Suppl 1():461-4. PubMed ID: 6664224
[TBL] [Abstract][Full Text] [Related]
24. Stereospecific reduction by narcotic antagonists of clonidine-induced food intake.
Katz NL; Schlemmer RF; Waller DP
Pharmacol Biochem Behav; 1985 Apr; 22(4):649-51. PubMed ID: 3991774
[TBL] [Abstract][Full Text] [Related]
25. A species difference in the slowing effect of intrathecal morphine on gastrointestinal transit.
Vaught JL; Cowan A; Gmerek DE
Eur J Pharmacol; 1983 Oct; 94(1-2):181-4. PubMed ID: 6689154
[TBL] [Abstract][Full Text] [Related]
26. The possible involvement of alpha-adrenoceptors in the intestinal effect of nalbuphine in mice.
Wong CL
Methods Find Exp Clin Pharmacol; 1990 Nov; 12(9):601-4. PubMed ID: 1964710
[TBL] [Abstract][Full Text] [Related]
27. Central kappa- and mu-opiate receptors mediate ACTH-release in rats.
Pfeiffer A; Herz A; Loriaux DL; Pfeiffer DG
Endocrinology; 1985 Jun; 116(6):2688-90. PubMed ID: 2986960
[TBL] [Abstract][Full Text] [Related]
28. Relative involvement of receptor subtypes in opioid-induced inhibition of gastrointestinal transit in mice.
Ward SJ; Takemori AE
J Pharmacol Exp Ther; 1983 Feb; 224(2):359-63. PubMed ID: 6296358
[No Abstract] [Full Text] [Related]
29. Evidence for opiate action at the brain receptors for thyrotropin-releasing hormone.
Bhargava HN; Das S
Brain Res; 1986 Mar; 368(2):262-7. PubMed ID: 3008927
[TBL] [Abstract][Full Text] [Related]
30. Stimulant effect of thyrotropin-releasing hormone and its analog, RGH 2202, on the diaphragm respiratory activity, and their antagonism with morphine: possible involvement of the N-methyl-D-aspartate receptors.
Kharkevich DA; Chizh BA; Kasparov SA
Brain Res; 1991 Jun; 551(1-2):110-5. PubMed ID: 1833029
[TBL] [Abstract][Full Text] [Related]
31. Orally administered kappa as well as mu opiate agonists delay gastrointestinal transit time in the guinea pig.
Culpepper-Morgan J; Kreek MJ; Holt PR; LaRoche D; Zhang J; O'Bryan L
Life Sci; 1988; 42(21):2073-7. PubMed ID: 2838706
[TBL] [Abstract][Full Text] [Related]
32. Thyrotropin-releasing hormone receptors in gut tissues resemble pituitary receptors.
Lotti VJ; Chang RS; Cerino DJ; Kling PJ; Veber DF; Nutt RF
Neurosci Lett; 1986 Feb; 64(2):173-6. PubMed ID: 3008042
[TBL] [Abstract][Full Text] [Related]
33. Effect of thyrotropin releasing hormone on U-50,488H-induced pharmacological responses in mice.
Bhargava HN; Thorat SN
Brain Res; 1993 Oct; 625(1):120-4. PubMed ID: 8242390
[TBL] [Abstract][Full Text] [Related]
34. TRH-induced antinociception: interaction with the opioid systems?
Reny-Palasse V; Poncet J; Rips R
Gen Pharmacol; 1987; 18(2):179-83. PubMed ID: 3032733
[TBL] [Abstract][Full Text] [Related]
35. Role of opiate receptors in the regulation of colonic transit.
Kaufman PN; Krevsky B; Malmud LS; Maurer AH; Somers MB; Siegel JA; Fisher RS
Gastroenterology; 1988 Jun; 94(6):1351-6. PubMed ID: 2834257
[TBL] [Abstract][Full Text] [Related]
36. Effects of the benzomorphan kappa-opiate, MR 2266 and its (+) enantiomer MR 2267, on thermonociceptive reactions in different strains of mice.
Bansinath M; Ramabadran K; Turndorf H; Puig MM
Neurosci Lett; 1990 Sep; 117(1-2):212-7. PubMed ID: 1963214
[TBL] [Abstract][Full Text] [Related]
37. Independent central and peripheral mediation of morphine-induced inhibition of gastrointestinal transit in rats.
Gmerek DE; Cowan A; Woods JH
J Pharmacol Exp Ther; 1986 Jan; 236(1):8-13. PubMed ID: 3941402
[TBL] [Abstract][Full Text] [Related]
38. The role of CRF in the release of ACTH by opiate agonists and antagonists in rats.
Nikolarakis K; Pfeiffer A; Stalla GK; Herz A
Brain Res; 1987 Sep; 421(1-2):373-6. PubMed ID: 2825911
[TBL] [Abstract][Full Text] [Related]
39. Antinociceptive properties of thyrotropin releasing hormone in mice: comparison with morphine.
Boschi G; Desiles M; Reny V; Rips R; Wrigglesworth S
Br J Pharmacol; 1983 May; 79(1):85-92. PubMed ID: 6409194
[TBL] [Abstract][Full Text] [Related]
40. Thyrotropin-releasing hormone stimulates intestinal transit in young rats.
Bond E; Heitkemper M
Regul Pept; 1990 Feb; 27(2):263-71. PubMed ID: 2109338
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
